HIV/AIDS
Showing page 5 of 8 pages of list content
-
Durability of ChAdOx1 nCov-19 (AZD1222) vaccination in people living with HIV - responses to SARS-CoV-2, variants of concern and circulating coronaviruses
This article's authors -
Immunogenicity and safety of an inactivated SARS-CoV-2 vaccine in people living with HIV-1
This article's authors -
Reduction in initiations of HIV treatment in South Africa during the COVID pandemic
This article's authors -
Inexpensive workflow for simultaneous monitoring of HIV viral load and detection of SARS-CoV-2 infection
This article's authors -
Intention to receive a COVID-19 vaccine by HIV status among a population-based sample of women and gender diverse individuals in British Columbia, Canada
This article's authors -
Increasing Numbers of Non-communicable Disease Co-morbidities: Major Risk Factors for Hospitalization among a Cohort of People with HIV and COVID-19 Coinfection
This article's authors -
Influence of Novel Coronavirus COVID – 19 and HIV: A Scoping Review of Hospital Course and Symptomatology
This article's authors -
Global and regional prevalence and outcomes of COVID-19 in people living with HIV: A cutting-edge systematic review and meta-analysis
This article's authors -
The risk of severe COVID-19 and mortality from COVID-19 in people living with HIV compared to individuals without HIV - a systematic review and meta-analysis of 1 268 676 individuals
This article's authors -
Seroprevalence of COVID-19 in HIV Population
This article's authors